MiR-224-3p regulates ferroptosis and inflammation in lens epithelial cells by targeting ACSL4

Feng Sun1, Na Li1, Yan Liu1

  • 1Department of Ophthalmology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, 233004, China.

Experimental Eye Research
|February 22, 2025
PubMed

Insights

MicroRNA-224-3p (miR-224-3p) protects against ferroptosis and inflammation in high myopia cataract (HMC) by targeting ACSL4. This finding offers potential therapeutic strategies for HMC by modulating miR-224-3p levels.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Cell Biology

Background:

  • High myopia cataract (HMC) is associated with lens epithelial cell dysfunction.
  • Ferroptosis and inflammation are implicated in cataract development.
  • The role of microRNAs in HMC pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the expression of miR-224-3p and its target ACSL4 in HMC.
  • To determine the effect of miR-224-3p on ferroptosis and inflammation in human lens epithelial cells (HLECs).
  • To explore the therapeutic potential of miR-224-3p in HMC.

Main Methods:

  • RNA sequencing and qPCR to analyze gene expression in HMC and age-related cataract (ARC) tissues.
  • Immunohistochemistry and transmission electron microscopy to assess cellular and mitochondrial changes.
  • Dual-luciferase reporter assays and Western blot to confirm the interaction between miR-224-3p and ACSL4.
  • In vitro experiments using HLECs treated with TNF-α and erastin to induce inflammation and ferroptosis.

Main Results:

  • miR-224-3p expression was significantly upregulated in HMC compared to ARC.
  • ACSL4 expression was downregulated in HMC, and it was identified as a direct target of miR-224-3p.
  • miR-224-3p inhibited erastin-induced ferroptosis by reducing Fe2+, MDA, and ROS levels, and increasing GPX4 and GSH levels.
  • miR-224-3p suppressed TNF-α-induced inflammation by decreasing IL-6 expression.
  • miR-224-3p promoted HLEC proliferation and migration, and increased cell viability by regulating ferroptosis and inflammation via ACSL4.

Conclusions:

  • miR-224-3p plays a protective role in HMC by suppressing ferroptosis and inflammation.
  • The miR-224-3p/ACSL4 axis is a key regulator of these processes in HLECs.
  • Targeting miR-224-3p may represent a novel therapeutic strategy for HMC.

Related Concept Videos